Related Experiment Video
Updated: Mar 26, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Difference between early onset and late-onset pediatric ulcerative colitis
Ryusuke Nambu1, Shin-Ichiro Hagiwara2, Mitsuru Kubota2
1Division of General Pediatrics, Saitama Children's Medical Center, Saitama, Japan. nambee1231@gmail.com.
Insights
Early onset pediatric ulcerative colitis (EO-UC) presents with more pancolitis and extra-intestinal issues, often with a longer diagnostic delay compared to late onset UC. Diagnosis and treatment can be more challenging for EO-UC patients.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Epidemiology
Background:
- Early onset ulcerative colitis (EO-UC) differs from late onset UC (LO-UC) due to genetic factors.
- Limited data exists on EO-UC clinical features in Asian populations.
Purpose of the Study:
- To compare the clinical presentation and disease course of EO-UC (0-7 years) with LO-UC (8-15 years).
- To identify differences in diagnosis, disease extent, and complications between EO-UC and LO-UC.
Main Methods:
- Retrospective analysis of 63 pediatric UC patients diagnosed between 2004-2014 in Japan.
- Comparison of EO-UC (n=10) and LO-UC (n=53) groups based on clinical data.
Main Results:
- EO-UC patients showed a higher incidence of pancolitis (100% vs 70%) compared to LO-UC.
- Diagnostic delay was significantly longer in EO-UC (9.0 months vs 2.6 months).
- Extra-intestinal complications were more prevalent in EO-UC (50% vs 11%) at diagnosis.
Conclusions:
- EO-UC is associated with pancolitis, delayed diagnosis, and increased extra-intestinal manifestations.
- Diagnosis and management of EO-UC may present greater challenges than LO-UC.
Background:
Early onset pediatric ulcerative colitis (EO-UC) is distinguished from late-onset pediatric ulcerative colitis (LO-UC) by the effects of genetic predisposition, but there have been few reports on the clinical features of EO-UC in Asia.
Methods:
To describe and compare the presentation and disease course of EO-UC (age range, 0-7 years) with those of LO-UC (age range, 8-15 years), we retrospectively analyzed 63 children with UC who had been diagnosed between January 2004 and March 2014 at Saitama Children's Medical Center in Japan.
Results:
Ten patients (16%) had EO-UC, and 53 (84%) had LO-UC. All patients in the EO-UC group and 70% in the LO-UC group had pancolitis (P = 0.05). The period from onset to diagnosis was 9.0 ± 14.1 months for EO-UC and 2.6 ± 3.5 months for LO-UC (P < 0.01). The prevalence of extra-intestinal complications at diagnosis was significantly higher for EO-UC than for LO-UC (50% vs 11%, respectively; P < 0.01). There were no significant differences in the use of corticosteroids, immunomodulators, immunosuppressants, or surgical risk between the groups but, in the EO-UC group, only one patient was treated with cytapheresis and none was treated with anti-tumor necrosis factor (TNF-α) antibodies.
Conclusions:
The EO-UC group had a higher incidence of pancolitis, longer diagnostic delay, and more extra-intestinal manifestations than the LO-UC group. Diagnosis and treatment may therefore be slightly more difficult for EO-UC than for LO-UC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Peptic Ulcer
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

